Relevance of platinum sensitivity status in relapsed/refractory extensive stage small cell lung cancer (ES-SCLC) in the modern era: A patient level analysis of SWOG trials

BACKGROUND: Extensive stage small cell lung cancer (ES-SCLC) patients who progress following platinum-based chemotherapy are traditionally categorized as platinum-sensitive (progression ≥ 90 days from last platinum dose) or refractory (progression< 90 days), apractice arising from seminal observa...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Thorac Oncol
Main Authors: Lara, Primo N., Moon, James, Redman, Mary W., Semrad, Thomas J., Kelly, Karen, Allen, Jeffrey W., Gitlitz, Barbara J., Mack, Philip C., Gandara, David R.
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4320001/
https://ncbi.nlm.nih.gov/pubmed/25490004
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/JTO.0000000000000385
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados